Laryngeal Cryotherapy for Refractory Neurogenic Cough

Recruiting Observational Study
Upper-Airway Cough Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
28 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients 18 years or older with diagnosis of neurogenic cough * Neurogenic cough is a diagnosis of exclusion applied to persistent cough (8 weeks or longer) * Negative workup for other causes, including sinonasal allergies/chronic sinusitis, cough-variant asthma, and GER…
Contacts

Shumon Dhar, MD

214-645-7034

Shumon.Dhar@UTSouthwestern.edu

CONTACT

Paula Arellano-Cruz

214-648-8096

Paula.Arellano-Cruz@UTSouthwestern.edu

CONTACT